Is Bajaj Healthcare technically bullish or bearish?

Dec 02 2025 09:11 AM IST
share
Share Via
As of December 1, 2025, Bajaj Healthcare's technical trend has shifted to a moderate bearish stance, indicated by bearish MACD, Bollinger Bands, and moving averages, despite a mildly bullish KST signal on the weekly chart.




Technical Trend Shift and Moving Averages


As of 01 Dec 2025, Bajaj Healthcare's technical trend has shifted from mildly bearish to outright bearish. This transition reflects increasing selling pressure and a weakening price structure. The daily moving averages, a critical gauge of short-term momentum, remain firmly bearish, indicating that the stock price is trading below its average levels and suggesting a continuation of downward momentum in the near term.


Momentum Indicators: MACD and KST Analysis


The Moving Average Convergence Divergence (MACD) indicator, widely used to assess trend strength and direction, presents a bearish signal on the weekly chart and a mildly bearish stance on the monthly timeframe. This divergence implies that while the short-term momentum is clearly negative, the longer-term trend is only moderately weak, leaving room for potential stabilisation if positive catalysts emerge.


Conversely, the Know Sure Thing (KST) indicator offers a nuanced view. It is mildly bullish on the weekly scale but mildly bearish monthly, highlighting a conflict between short-term optimism and longer-term caution. This mixed reading suggests that while some short-term buying interest exists, it is insufficient to reverse the broader downtrend.


Volatility and Relative Strength Indicators


Bollinger Bands, which measure price volatility and potential overbought or oversold conditions, are signalling bearishness on both weekly and monthly charts. This indicates that the stock price is likely experiencing downward pressure within a widening volatility range, often a precursor to further declines or consolidation at lower levels.


The Relative Strength Index (RSI), however, does not currently provide a clear signal on either weekly or monthly timeframes. The absence of a definitive RSI reading suggests that the stock is neither overbought nor oversold, reinforcing the notion of a consolidating or weakening trend rather than an imminent reversal.


Volume and Dow Theory Perspectives


On-Balance Volume (OBV), a volume-based indicator used to confirm price trends, shows no discernible trend on weekly or monthly charts. This lack of volume confirmation weakens the conviction behind any price moves, implying that neither buyers nor sellers are dominating decisively.


Similarly, Dow Theory analysis reveals no clear trend on weekly or monthly scales, underscoring the absence of a strong directional consensus in the market for Bajaj Healthcare shares.


Price Action and Key Levels


Currently, Bajaj Healthcare is trading at ₹430.50, slightly below the previous close of ₹434.40. The stock has seen a 52-week high of ₹744.90 and a low of ₹374.00, indicating a wide trading range over the past year. The recent price action near the lower end of this range suggests the stock is under pressure, with limited upside momentum.


Today's intraday range between ₹429.10 and ₹440.00 further reflects subdued volatility, consistent with the technical indicators signalling consolidation or a bearish bias.



Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.



  • - Consistent quarterly delivery

  • - Proven staying power

  • - Stability with growth



See the Consistent Performer →



Comparative Returns and Market Context


Examining Bajaj Healthcare's returns relative to the Sensex reveals a challenging performance backdrop. Over the past month, the stock has declined by 9.5%, contrasting with the Sensex's modest 2.0% gain. Year-to-date, the divergence is starker, with Bajaj Healthcare down 26.2% while the benchmark index has advanced 9.6%.


However, over a one-year horizon, the stock has marginally outperformed the Sensex, delivering a 7.7% return compared to the index's 7.3%. Longer-term returns over three and five years show the stock lagging the broader market, with cumulative gains of 7.7% and 85.4% respectively, versus the Sensex's 35.3% and 91.8%. This mixed performance underscores the stock's volatility and sector-specific challenges.


Sectoral and Industry Considerations


Operating within the Pharmaceuticals & Biotechnology sector, Bajaj Healthcare faces industry-specific headwinds including regulatory scrutiny, pricing pressures, and competitive dynamics. These factors often contribute to heightened volatility and can exacerbate bearish technical signals. Investors should weigh these sectoral risks alongside the technical outlook when considering exposure to the stock.



Why settle for Bajaj Healthcare? SwitchER evaluates this Pharmaceuticals & Biotechnology Smallcap against peers, other sectors, and market caps to find you superior investment opportunities!



  • - Comprehensive evaluation done

  • - Superior opportunities identified

  • - Smart switching enabled



Discover Superior Stocks →



Technical Outlook and Investor Implications


In aggregate, the technical indicators for Bajaj Healthcare lean towards a bearish stance. The shift from mildly bearish to bearish trend, combined with negative MACD readings and bearish moving averages, suggests that the stock may face continued downward pressure in the short to medium term.


While some mildly bullish signals on weekly KST and neutral RSI readings hint at potential short-term stabilisation, these are insufficient to counterbalance the dominant bearish momentum. The absence of volume confirmation and lack of clear Dow Theory trends further reinforce the cautious outlook.


Investors should remain vigilant and consider these technical signals alongside fundamental factors and broader market conditions. Those with a higher risk tolerance might monitor for signs of a technical reversal or improved sector sentiment before increasing exposure. Conversely, risk-averse investors may prefer to reduce holdings or seek alternative opportunities within the pharmaceuticals and biotechnology space.


Conclusion


Bajaj Healthcare currently exhibits a predominantly bearish technical profile, marked by weakening momentum and downward price pressure. Despite some short-term bullish nuances, the overall trend and key indicators advise caution. Investors should carefully assess risk and consider broader market and sector dynamics before making investment decisions related to this stock.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News